Indication

Non-infectious uveitis affecting the posterior segment of eye

Non-infectious uveitis affecting the posterior segment of the eye is a sight-threatening intraocular inflammatory disorder characterized by immune-mediated inflammation involving the choroid, retina, optic nerve, or adjacent vitreous humor in the absence of an infectious pathogen. Read more about Non-infectious uveitis affecting the posterior segment of eye

9 drugs 8 manufacturers

Advertisement

Drugs that treat it

Common Non-infectious uveitis affecting the posterior segment of eye therapies.

Showing 1–9 of 9 drugs

Filter & compare in the drug finder →Opens the drug finder with Non-infectious uveitis affecting the posterior segment of eye preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Non-infectious uveitis affecting the posterior segment of eye.

Non-infectious uveitis affecting the posterior segment of the eye is a sight-threatening intraocular inflammatory disorder characterized by immune-mediated inflammation involving the choroid, retina, optic nerve, or adjacent vitreous humor in the absence of an infectious pathogen.

Most commonly diagnosed in working-age adults, it may present as an isolated ocular syndrome or arise secondary to systemic autoimmune diseases, such as sarcoidosis, Behçet disease, or Vogt-Koyanagi-Harada syndrome.

Pathophysiologically driven by dysregulated, T-cell-mediated immune responses, this condition manifests clinically with vitreous haze, chorioretinal lesions, retinal vasculitis, or optic disc swelling, frequently leading to profound visual decline through complications such as cystoid macular edema and irreversible retinal scarring.

Personalize your experience

Follow Non-infectious uveitis affecting the posterior segment of eye and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it